Welcome to the McGill Antimicrobial Resistance Centre! Antimicrobial Resistance (AMR) is one of the top ten global public health threats. It is an urgent and complex problem that poses major health and economic threats, both within Canada and worldwide. Tackling this impending public health crisis demands innovative, interdisciplinary, and collaborative research solutions that no single sector or approach can address alone.
AMR Centre Events and Announcements
AMR Centre members Jennifer Ronholm and Makeda Semret in the news!
Résistance aux antibiotiques
"Les bactéries contrattaquent"
by Mathieu Perreault | La Presse
Posted Dec 5 2025
Montreal Medical Experts Address Rising Antibiotic Resistance
AMR Centre and Outreach is in the news!
Interviews and article
by Johanie Bouffard
Montreal City News
Posted November 18, 2025
Canadian Parliament Reviews
National Response to AMR
The House of Commons Standing Committee on Science and Research launched a multi-session study on AMR to examine its causes, clinical and economic impacts nationwide, and to identify research priorities for developing new treatments and strategies to combat resistant infections. Testimonies, including those by Dao Nguyen, director of the AMR Centre, are now available.
Spotlight on the McGill AMR Centre!
"From discovery to solutions: McGill’s multidisciplinary and collaborative approach to combating antimicrobial resistance"
Rapport de synthèse de la journée de concertation du réseau AntiMicrobio Résistance Québec (AMRQ) | décembre 2025
Canadian Academy of Health Sciences (CAHS), Report: Assessment on Antimicrobial Resistance and Antimicrobial Use in Food Producing Animals | March 2025
This document presents a new WHO initiative to strengthen diagnostic capacity to improve the diagnosis and management of bacterial and fungal infections and associated AMR.
Antimicrobials have been an important pillar of our medical system since the 1930s. In addition, they play an enormous role in our food-supply system as they are used to treat, control, and prevent disease in agricultural animals that improve production, health, and reproduction. Agriculture accounts for about 82% of antibiotic use in Canada.
However, antimicrobial resistance (AMR) is becoming an increasingly concerning global issue. There were about 4.95 million deaths associated with bacterial AMR in 2019 . This is a major problem for the stability of our health care system!
McGill Innovation Fund launches 4th edition with major support from Desjardins
North America’s largest co-operative financial group to contribute $500,000 for entrepreneurial competition’s top-tier awards
Spotlight on the McGill AMR Centre!
"McGill AMR Centre: Tackling the global threat of antimicrobial resistance through collaborative and interdisciplinary research"
Antibiotic-Free Treatment for Infection?
New Technology with Potential in the Fight Against Antimicrobial Resistance
New treatment under development could potentially treat intracellular infections without the need for traditional antibiotics.
